C82.2
Follicular lymphoma grade III, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Follicular lymphoma is a type of blood cancer that affects the lymphatic system. It originates in the lymph nodes, which are small, bean-shaped structures involved in fighting infections. Grade III indicates an advanced form of this lymphoma, characterized by the appearance of more aggressive cancer cells. This condition is categorized under ICD-10 code C82.2 and is sometimes referred to as an indolent or slow-growing lymphoma, but with more aggressive features in grade III. Early understanding and appropriate medical care are important for managing this disease effectively.
Causes & Symptoms
Clinical Causes: Genetic mutations: Changes in the DNA of lymphocytes can lead to uncontrolled growth. Environmental factors: Exposure to certain chemicals or radiation may increase risk. Age: It is more common in older adults, typically those over 60. Immune system disorders: Conditions that weaken immune defenses can contribute. Family history: A history of lymphoma or other lymphatic diseases in relatives.
Key Symptoms: Swollen lymph nodes in the neck, armpits, or groin that are painless and persistent. Unexplained weight loss. Fever that comes and goes. Night sweats. Fatigue or weakness. Abdominal pain or swelling if the lymph nodes in the abdomen are affected. Loss of appetite. Itching all over the body.
Diagnostic & Treatment
Diagnosis Path: Physical examination: Checking for enlarged lymph nodes and other signs. Blood tests: Complete blood count (CBC) and other blood work to evaluate overall health. Imaging studies: CT scans or PET scans to identify affected areas. Lymph node biopsy: Removing a lymph node or part of it to examine under a microscope, determining the grade and type of lymphoma. Bone marrow biopsy: Assessing if the cancer has spread to the bone marrow.
Treatment Protocols: Chemotherapy: Using anti-cancer drugs to target rapidly dividing cells. Immunotherapy: Employing medicines that help the immune system recognize and destroy cancer cells. Targeted therapy: Drugs that specifically attack cancer cells with certain genetic markers. Radiation therapy: Using high-energy rays to destroy localized cancer areas. Stem cell transplant: Replacing diseased bone marrow with healthy cells after intensive therapy. Watchful waiting: In some cases, especially if the disease progresses slowly, close monitoring may be recommended without immediate treatment.
Clinical Advice & FAQs
Billing Guidance
Is C82.2 a billable ICD-10 code?
Yes, C82.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C82.2?
Clinical documentation must specify the nature of Follicular lymphoma grade III, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference